rPfCSP + Lm-PfCSP vaccine (Protein Potential/Aduro)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamerPfCSP + Lm-PfCSP vaccine (Protein Potential/Aduro)
Drug Alias Namedual component vaccine (Protein Potential/Aduro Biotech)recombinant Plasmodium falciparum circumsporozoite protein + Lm expressing Plasmodium falciparum circumsporozoite protein vaccine (Protein Potential/Aduro)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtein Potential LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtein Potential LLCChinook Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A